Time-related Increase of Staphylococci, Enterobacteriaceae and Yeasts in the Oral Cavities of Comatose Patients  by Cecon, Fabrine et al.
Copyright © 2010 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved. 457
J Microbiol Immunol Infect 2010;43(6):457–463
Contents lists available at ScienceDirect
Journal of Microbiology, Immunology and Infection
Journal homepage: http://www.e-jmii.com
Microbiology, 
Infection
Immunology
Journal of 
and
  
Indexed in MEDLINE/Index Medicus, SCIE, BIOSIS, EMBASE,
Aidsline, CancerLit, Chemical Abstracts, HealthSTAR
Available online http://www.e-jmii.com
The official journal of
Taiwan Society of Microbiology
Chinese Society of Immunology
The Infectious Diseases Society of Taiwan
Taiwan Society of Parasitology
ISSN 1684-1182
Volume 43
Number 6
December 2010
*Corresponding author. Pontifícia Universidade Católica 
do Paraná, Centro de Ciências Biológicas e da Saúde, 
Laboratório de Estomatologia, Rua Imaculada Conceição 
1155–Prado Velho–80215-901–Curitiba, Brazil.
E-mail: edvaldo.rosa@pucpr.br
Article History:
Received: Jun 9, 2007
Revised: Feb 6, 2009
Accepted: Sep 23, 2009
Introduction
The oral microbiota are known to be the most diverse of 
those that colonize the epithelia and mucosa.1 Some oral 
bacteria may disseminate to internal organs and provoke 
systemic infections, especially in the case of pneumonia.2,3 
In many pneumonia cases, the involved oral microorgan-
isms may reach the lungs as the result of aspiration of saliva.4 
Apart from the organisms commonly found in the oral 
microbiota (streptococci, lactobacilli and Gram-negative 
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BACKGROUND/PURPOSE: The composition of oral microbiota in comatose patients remains uncertain. 
Some pulmonary pathogens may be found in dental biofilms or as part of the saliva microbiota. It is supposed 
that some pneumopathogenic microorganisms may overgrow in the mouths of comatose patients and 
spread to their lungs.
METHODS: The oral colonization dynamics of staphylococci, Enterobacteriaceae and yeasts in nine 
comatose patients (group 1), and in 12 conscious patients that brushed their teeth at least twice a day 
(group 2) was evaluated. Both groups were followed up for 7 days after hospitalization. Daily samples of 
saliva were obtained, dispersed and plated on selective culture media and colony forming units of each 
microbial group were obtained.
RESULTS: For patients in group 1, the counts of total viable bacteria, staphylococci, Enterobacteriaceae 
and yeasts progressively increased in a time-dependant manner. For the conscious patients of group 2, 
there was no increase.
CONCLUSION: It would appear that concomitant consciousness and brushing teeth are determinants 
in controlling the selected pneumopathogen counts in resting saliva. The increase in microbial counts in 
comatose patients is understandable because these microorganisms could spread to the lungs.
KEYWORDS: coma, Enterobacteriaceae, saliva, staphylococci, yeast
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anaerobic rods), transitory entities such as Staphylococcus 
aureus, Pseudomonas aeruginosa and Klebsiella pneumoniae may 
also grow in oral biofilms and be carried by saliva to the 
lungs when cell numbers are high, provoking acute pneu-
monia.5–7 Oral yeasts may also be associated with acute 
pneumonia, mainly in mechanically ventilated patients.8
Comatose patients, and those with severe traumatic 
brain injury, are not in control of their oral hygiene. 
Therefore, it is reasonable to suppose that these pulmo-
nary pathogens may easily overgrow in their mouths and 
reach the lungs, making the patients more prone to pul-
monary diseases.9 Moreover, many comatose patients re-
quire mechanical ventilation, meaning that maintaining 
adequate oral hygiene is very difficult for nursing staff, 
and this may increase the risk of pulmonary infection.10,11 
It is also believed that some oral cleansers do not benefit 
patients and do not decrease the incidence of nosocomial 
pneumonia in patients.12,13
Regardless of the potential importance of this matter, 
very little information regarding normal or hospital-acquired 
oral microbiota composition in comatose patients is 
available; very few publications report the prospective oral-
pulmonary infection pathway in these patients. The aim 
of this study was to investigate the impact of a lack of oral 
hygiene and time-dependent oral growth of some selected 
pneumonia-related microorganisms in institutionalized 
comatose patients. We opted to investigate the growth of sta-
phylococci, Enterobacteriaceae and Candida sp. because they 
are important species involved in nosocomial infections.
Methods
A formal agreement according to the guidelines estab-
lished by the Local Ethical Committee for Research 
Involving Human Beings was required for each patient in 
this study. Nine institutionalized adult patients from two 
hospitals in Curitiba (Brazil) that were diagnosed as being 
in a comatose state (Glasgow scale ≥ 6 and ≤ 8) and under-
going antibiotic therapy were enrolled in this study 
(group 1; Table).
Table. Descriptive data for patients and hospital history
Group Patient no. Coma etiology Age (yr)/sex Glasgow score Antibiotic therapy Coma evolution
1  1 CVS 42/M 8 Ceftriaxone + clindamycin Death from pneumonia
  2 Trauma 77/F 8 Cefepime + clarithromycin Woke from coma
  3 Trauma 28/F 7 Cefazolin Woke from coma
  4 MIC 42/M 6 Ceftazidime + clarithromycin Woke from coma
  5 CVS 23/M 6 Ceftriaxone + clarithromycin Death from pneumonia
  6 Trauma 40/M 7 Cefazolin Woke from coma
  7 Trauma 30/M 7 Cefazolin Death from pneumonia
  8 Trauma 37/M 8 Ceftriaxone + metronidazole Death from pneumonia
  9 MIC 48/F 7 Ceftriaxone Woke from coma
2 10 NC 53/F – – –
 11 NC 64/F – – –
 12 NC 23/M – – –
 13 NC 34/M – Cefazolin –
 14 NC 22/F – – –
 15 NC 45/M – – –
 16 NC 44/M – – –
 17 NC 51/F – Cefazolin –
 18 NC 67/M – Ceftriaxone –
 19 NC 19/M – – –
 20 NC 33/M – – –
  21 NC 23/F – – –
CVS = cerebral vascular stroke; MIC = medically induced coma; NC = non-comatose; M = male; F = female.
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In parallel, 12 conscious patients hospitalized for sur-
geries or trauma treatment were followed up for 7 days 
and formed the control group (group 2). These patients 
were able to brush their teeth at least twice a day and were 
not using any antibacterial mouth washes.
Saliva samples from patients were collected from the 
sublingual region using prewet sterile cotton balls and 
avoiding the dental plaque, tongue or lips. Baseline collec-
tions were taken immediately after the coma diagnoses or 
hospital admission and subsequently at 24 hour intervals. 
After sampling, the wet cotton balls were immediately 
sent to the laboratory and their mass were determined. 
After that, microbial cells were disrupted in 2 mL sterile 
saline by sonication (50 KHz, 100 W, 3 minutes).
Each bacterial suspension was serially diluted in sterile 
saline. Aliquots of 100 μL from each dilution were applied 
onto blood agar, mannitol salt agar (Difco Laboratories, 
Detroit, MI, USA), CHROMOcult Coliform Agar (Merck 
Diagnostics, Darmstadt, Germany) and CHROMagar 
Candida (CHROMagar, Paris, France) to determine the total 
number of viable staphylococci, Enterobacteriaceae and 
yeasts. Petri dishes with blood agar and mannitol salt agar 
were incubated at 35ºC for 24 hours. The CHROMOcult 
Coliform Agar and CHROMagar Candida plates were in-
cubated at 28ºC for 24 hours. Following incubation, plates 
with 30–300 colonies were chosen and the microbial counts 
determined. Colonies showing phenotypic differences in 
each culture medium were taken and submitted to comple-
mentary biochemical and physiological identification tests.14
When Klebsiella pneumoniae, K. oxytoca, or Escherichia coli 
was identified, a double-disk synergy test for extended 
spectrum β-lactamase (ESBL) detection was carried out. 
Disks containing ceftazidime (30 μg) and cefotaxime 
(30 μg) were placed 15 mm apart (edge to edge) from an 
amoxicillin (20 μg)-clavulanate (10 μg) disk. Imipenem 
(10 μg), meropenem (10 μg) and cefepime (30 μg) disks 
were also placed on this plate. Following incubation 
at 35ºC for 18–20 hours, a clear extension of the zone of 
inhibition between ceftazidime and/or cefotaxime and 
the amoxicillin (20 μg)-clavulanate (10 μg) disk was inter-
preted as positive for ESBL production.15 The K. pneumoniae 
ATCC 700603 (ESBL positive) and E. coli ATCC 25922 
(ESBL negative) strains were used for control.
The normality of all data were checked using the 
Kolmorogov–Smirnov and Shapiro–Wilk tests; subsequently, 
the nonparametric test of Kruskal–Wallis was applied to 
calculate any statistical differences between the microbial 
counts in the saliva collected from the patients in both 
groups. Differences between the baseline and the last days 
of sample collection were also evaluated by the nonpara-
metric test of Kruskal–Wallis. The growth of different 
microbial groups was assessed by the correlation product, 
based on the Pearson moment in relation to the total viable 
microorganism counts.
Results
Of nine patients in group 1 (comatose patients), four could 
be followed up for 7 days, one for 6 days, one for 5 days 
and three for 4 days. After these periods, five patients had 
woken from their coma and the remaining four had died 
from pneumonia, as confirmed by a physician after necropsy. 
The microbial counts in the patients who died were lower 
than that in the comatose patients (p = 0.634). Patients 
from group 2 (control group) were followed up for 6 days 
after their hospitalization, with the exception of patient 
19, who left hospital after 5 days.
The total viable bacteria counts in patients from group 
1 varied from 1.1 ± 0.9 × 104 CFU/mL at the baseline up to 
5.2 ± 2.8 × 106 CFU/mL, 6 days later. Differences between the 
first and last days were statistically significant (p < 0.001). 
Patients in group 2 exhibited counts that varied from 
3.3 ± 2.4 × 103 CFU/mL (on the day of hospitalization) to 
4.1 ± 2.1 × 103 CFU/mL (6 days later). No statistical differ-
ences were observed between these days (p = 0.401) for 
patients from group 2 (Figure 1).
Figure 2 shows that all patients in group 1 harbored 
staphylococci in their mouths initially (8.0 ± 3.7 × 101 
CFU/mL), with the counts increasing (3.2 ± 1.9 × 104 CFU/
mL) over the time of hospitalization (p < 0.001). The same 
progression was not observed in the patients from group 2 
(p = 0.235). For patients from both groups, 10 mannitol 
fermentative colonies were randomly chosen and further 
identified as S. aureus.
Progressive colonization (p < 0.001) of Enterobacte-
riaceae (Figure 3) was observed in all patients from group 1 
(4.1 ± 2.8 × 102 CFU/mL increased to 4.7 ± 2.3 × 104 CFU/mL), 
but not in patients from group 2 (p = 0.110). Among the 
bacteria of this group, species from the genus Klebsiella 
were predominant in patients 1, 5 and 6. Ten to 15 colonies 
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from each of these patients were tested for indole/Voges-
Proskauer. All of these specimens were negative for both 
tests. These were interpreted as putative results for 
K. pneumoniae. The remaining patients presented with a 
predominance of Klebsiella-like colonies (approximately 
90–95%). Colonies suggestive of E. coli were also detected 
(approximately 5–10%) in both patient groups. No ESBL 
strains were obtained amongst the Enterobacteriaceae.
The number of colonies grown on CHROMagar 
Candida increased from 4.1 ± 3.3 × 102 CFU/mL to 3.4 ± 
2.5 × 104 CFU/mL during the hospitalization period (p < 
0.001) for patients in group 1 (Figure 4). For patients in 
group 2, differences in the baseline counts and towards 
the last days of the study were not statistically significant 
(p = 0.079). In both groups, the phenotypic aspect of col-
onies was predominantly indicative of Candida albicans. 
The unique exception one patient from group 2 who ex-
hibited mixed colonization, presumably by C. albicans and 
C. tropicalis; these increased simultaneously throughout 
the hospitalization period. Further identification tests 
were not carried out.
All microorganism groups showed a positive linear cor-
relation when compared with the total viable microorganism 
counts for both patient groups. For group 1, correlation 
p 
<
0.
00
1
p 
=
0.
40
1
1,0E+03
1,0E+04
1,0E+05
1,0E+06
1,0E+07
Comatose
Non-comatose
Co
m
a
dia
gn
os
is
1
st  d
ay
2
nd  d
ay
3
rd  d
ay
4
th  d
ay
5
th  d
ay
6
th  d
ay
Figure 1. Six-day oral colonization dynamics of total countable 
bacteria.
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Figure 2. Six-day oral colonization dynamics of staphylococci.
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Figure 3. Six-day oral colonization dynamics of 
Enterobacteriaceae.
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Figure 4. Six-day oral colonization dynamics of yeasts.
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coefficients were 0.5911 for staphylococci (p < 0.001), 0.5493 
for Enterobacteriaceae (p < 0.001), and 0.393 for yeasts (p = 
0.004). For group 2, the correlation coefficient values were 
0.988 for staphylococci (p < 0.001), 0.924 for Enterobac-
teriaceae (p < 0.001), and 0.949 for yeasts (p < 0.001).
Discussion
The results obtained were not unexpected but warrant 
discussion. We hypothesized that some incremental in-
crease in microbial loads should be expected; however, the 
results showed the worst scenario where microorganisms 
with known pneumopathogenic potential9,12 tended to 
increase exponentially during the hospitalization time.
It was observed that the hospital nursing staff gave lit-
tle and inadequate attention to the oral hygiene of those 
comatose patients with dental plaques obviously visible. 
Besides the increase in microbial population, intense hali-
tosis was observed after 2 or 3 days of hospitalization 
(data not shown). As soon as these results were obtained, 
the hospitals’ Committees for Infection Control and the 
Nursing Care Service were informed, and both hospitals 
altered their conduct in relation to the oral hygiene of 
unconscious patients.
As shown in Figure 1, there was a time-dependent in-
crease in the total microbial cell numbers recovered from 
comatose patients. This result could be expected because 
such patients did not receive any oral care throughout 
their time in hospital. The group 2 patients that brushed 
their teeth had an unchanged microbial population dur-
ing the course of hospitalization. Myrianthefs et al16 re-
viewed the factors associated with nosocomial pneumonia 
and pointed out that patients must receive good oral at-
tention, including frequent suctioning of oral secretions 
and application of oral rinses twice daily, especially in 
those patients under pulmonary ventilation.
The choice of microorganisms evaluated in this study was 
based on the findings of other groups.8,17–22 Some of these 
microorganisms are supplementary to normal oral micro-
biota. Pseudomonades and other glucose non-fermentative 
Gram-negative bacilli were expected but not detected, 
probably because of technical problems associated with 
culture medium handling. It has been shown that S. aureus, 
P. aeruginosa and Enterobacteriaceae might participate in the 
dental biofilm composition of patients from intensive care 
units.7,23 In this study, respiratory pathogens were detected 
initially in all patients, which reinforces the idea that the oral 
cavity of comatose patients may become a favorable source 
for pathogens associated with pneumonia. Patients 4 and 
9 presented with high counts for staphylococci when coma 
was induced, possibly because these patients had been insti-
tutionalized for several days before medical coma induction.
Significant positive correlation among the total viable 
microorganisms and the three different groups (staphylo-
cocci, Enterobacteriaceae and yeasts) reinforced our opinion 
that such microorganisms, known to be pneumonia-
provoking agents, encountered favorable conditions for 
growth in the mouth of patients in comas, and may be-
come a steady fraction of the oral microbiota. The posi-
tive correlation between bacterial counts in dental biofilm 
and saliva has been established previously.24,25 Thus it is 
reasonable to propose that lack of hygiene led to plaque ac-
cumulation, which served as a food source for salivary 
microbiota.26,27 The role of oral bacteria in lung diseases 
has received more attention recently. It has been reported 
that a great variety of bacteria, including anaerobes such as 
Prevotella spp. and Fusobacterium spp., could be isolated 
from bronchoalveolar samples.2 The authors of that study 
found a positive correlation between the high values of 
plaque indexes and positive pulmonary recovery of anaer-
obes in institutionalized elderly people undergoing severe 
aspirative pneumonia.
The antibiotic regimen of the comas patients was 
based on empirical experience in both hospitals. Apparently, 
the anti-pneumonia antibiotics prescribed did not affect 
the bacterial growth in the oral cavity of comatose pa-
tients. Although these drugs are effective against a broad 
bacterial range, salivary clearance is not significant for 
clindamycin and cefoxitin.28,29 Recently, it was demon-
strated that although detectable cefazolin levels in serum 
have significant effect against salivary bacteria, the con-
centrations are low in the saliva and do not reach the min-
imum inhibitory concentration.30 Ceftriaxone, which has 
a good salivary secretion rate,31 did not prevent pathogen 
development in the oral environment, probably due to 
bacterial resistance and/or salivary rate decrease. Although 
all nine comatose patients were colonized by Candida sp., 
none were put on an antifungal regimen. Some drugs, 
especially the azoles, have shown efficacy against yeast 
cells due to their good salivary concentration levels.32–35 
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The prescription of azoles could be recommended since it 
is well known that Candida spp. are associated with pneu-
monia in hospitalized patients.36,37
Notwithstanding the importance of our results, 
there are limitations of this study. We did not state 
whether the microorganisms evaluated in this study were 
community or hospital strains. To determine this, molec-
ular fingerprinting needs to be employed. We supposed 
that those strains that increased in number during the 
hospitalization period were present in patients prior to 
their hospitalization, with the numbers already high when 
comas were diagnosed. Additionally, in the first 24 hours 
the numbers of these bacteria increased in an exponential 
fashion. The profiles of sensitivity to antibiotics for these 
microorganisms were not evaluated. If they were identi-
fied, we could also establish the time-related resistance 
increase, if any occurred. Also, in those patients whose 
cause of death was diagnosed as pneumonia, we had no 
access to the biological (pulmonary) material. Thus it was 
not possible to determine whether these microorganisms 
were actually involved or responsible for those deaths.
Despite these missing data, our results lead us to con-
clude that some pulmonary pathogens colonize the oral 
cavity of comatose patients and grow, as a result of the 
cessation of brushing and normal oral hygiene. This growth 
is progressive and may hypothetically disseminate to the 
lungs.38 Complementary studies must be carried out to 
establish colonization patterns of other pathogens such as 
P. aeruginosa, Acinetobacter baumannii, Streptococcus pneumoniae 
and Haemophilus influenza, among others. Molecular typing 
of microorganisms simultaneously harvested from the oral 
cavity and lungs may contribute to the elucidation of this 
putative oro-pulmonary infection pathway.
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